These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6591504)

  • 1. [Immunologic phenotype of blast cells in patients with myelocytic leukemia and its clinical significance].
    Baryshnikov AIu; Morozova LF; Frinovskaia IV; Volkova MA; Frenkel' MA
    Ter Arkh; 1984; 56(6):50-3. PubMed ID: 6591504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
    Baryshnikov AIu
    Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunologic phenotype of blast cells in the diagnosis of myeloblastic leukemias].
    Baryshnikov AIu; Volkova MA; Frenkel' MA; Tupitsyn NN; Morozova LF
    Ter Arkh; 1985; 57(5):98-100. PubMed ID: 3895550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
    Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
    Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell population analysis of a heterogeneous blast cell crisis of chronic myelogenous leukemia.
    Pedraza MA; Mason D; Doslu FA; Marsh RA; Boblett JP
    Diagn Immunol; 1984; 2(1):19-24. PubMed ID: 6594209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of an antigen, associated with cells during the blast crisis of chronic myeloleukemia, in a cytotoxic test using xenogenic antibodies].
    Baryshnikov AIu; Radzikhovskaia RM; Morozova LF; Slavina EG; Belianchikova NI
    Biull Eksp Biol Med; 1977 Jun; 83(6):719-21. PubMed ID: 267492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific xenogenous antiserum to cells of chronic myeloid leukemia (CML) in blastic crisis.
    Baryshnikov AJ; Radzikhovskaya RM; Morozova LF; Belyanchikova NI; Slavina EG; Vinogradova JE; Mkheidze DM; Polotskaya TM; Volkova MA; Svet-Moldavsky GJ; Nikitin VD; Kutimov VA; Trubitsina VI; Goletsky SA; Glazunov A
    Biomedicine; 1976 Dec; 25(9):316-7. PubMed ID: 1069594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
    Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of Fc- and C3-receptors on membranes of blast cells in myeloblastic leukemia and blast crisis of myelocytic leukemia].
    Tishchenko LM; Guseva SA
    Eksp Onkol; 1985; 7(2):51-4. PubMed ID: 3859402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
    Shumak KH; Baker MA; Taub RN; Coleman MS
    Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
    Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
    Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
    Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
    Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia.
    Ritz J; Pesando JM; Notis-McConarty J; Clavell LA; Sallan SE; Schlossman SF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4771-5. PubMed ID: 6945904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
    Suárez L; Vidriales B; García-Laraña J; López A; Martínez R; Martín-Reina V; Tormo M; González-San Miguel JD; Lavilla E; García-Boyero R; Orfao A; San Miguel JF;
    Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural features of basophil and mast cell granulopoiesis in blastic phase Philadelphia chromosome-positive leukemia.
    Parkin JL; McKenna RW; Brunning RD
    J Natl Cancer Inst; 1980 Sep; 65(3):535-46. PubMed ID: 6931933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of clonal evolution in patients with myelocytic leukemia].
    Petukhov VI; Grasmane DV; Bondare DK; Baravika IIa; Medne IT
    Ter Arkh; 1984; 56(6):53-8. PubMed ID: 6591505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytological and cytochemical study of the blastic population the acute phase of chronic myeloid leukemia].
    Castoldi GL; Grusovin GD; Scapoli GL
    Minerva Med; 1975 Jul; 66(49):2378-86. PubMed ID: 1056512
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavior in vitro of long-term cultured bone marrow or blood cells from chronic myeloid leukemia: adhesion molecules and differentiation antigens as detected by immunocytochemistry.
    Pasternak G; Pasternak L
    Folia Biol (Praha); 1994; 40(6):439-54. PubMed ID: 7589702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
    Schmetzer HM; Gerhartz HH
    Exp Hematol; 1997 Jun; 25(6):502-8. PubMed ID: 9197328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic evaluation of chronic myeloid leukemia.
    Moore MA; Mertelsmann R; Pelus LM
    Blood Cells; 1981; 7(2):217-36. PubMed ID: 6945881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.